nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—Doxorubicin—sarcoma	0.765	1	CbGbCtD
Bimatoprost—PTGER3—mammary gland—sarcoma	0.0109	0.109	CbGeAlD
Bimatoprost—PTGER3—myometrium—sarcoma	0.00772	0.0772	CbGeAlD
Bimatoprost—AKR1C3—Podofilox—Etoposide—sarcoma	0.0073	0.592	CbGdCrCtD
Bimatoprost—PTGER3—connective tissue—sarcoma	0.00638	0.0638	CbGeAlD
Bimatoprost—PTGFR—myometrium—sarcoma	0.00617	0.0617	CbGeAlD
Bimatoprost—PTGER3—smooth muscle tissue—sarcoma	0.00584	0.0584	CbGeAlD
Bimatoprost—AKR1C3—Vinblastine—Vincristine—sarcoma	0.00502	0.408	CbGdCrCtD
Bimatoprost—AKR1C3—myometrium—sarcoma	0.00502	0.0502	CbGeAlD
Bimatoprost—PTGER3—uterus—sarcoma	0.00501	0.0501	CbGeAlD
Bimatoprost—PTGFR—smooth muscle tissue—sarcoma	0.00467	0.0467	CbGeAlD
Bimatoprost—AKR1C3—seminal vesicle—sarcoma	0.00453	0.0453	CbGeAlD
Bimatoprost—PTGFR—uterus—sarcoma	0.004	0.04	CbGeAlD
Bimatoprost—AKR1C3—smooth muscle tissue—sarcoma	0.00379	0.0379	CbGeAlD
Bimatoprost—PTGER3—testis—sarcoma	0.00363	0.0363	CbGeAlD
Bimatoprost—PTGFR—tendon—sarcoma	0.00351	0.0351	CbGeAlD
Bimatoprost—AKR1C3—cardiac atrium—sarcoma	0.00327	0.0327	CbGeAlD
Bimatoprost—AKR1C3—uterus—sarcoma	0.00325	0.0325	CbGeAlD
Bimatoprost—PTGFR—testis—sarcoma	0.0029	0.029	CbGeAlD
Bimatoprost—Skin hyperpigmentation—Thiotepa—sarcoma	0.0029	0.0236	CcSEcCtD
Bimatoprost—AKR1C3—tendon—sarcoma	0.00285	0.0285	CbGeAlD
Bimatoprost—AKR1C3—bone marrow—sarcoma	0.00276	0.0276	CbGeAlD
Bimatoprost—PTGFR—liver—sarcoma	0.00275	0.0275	CbGeAlD
Bimatoprost—Urine abnormality—Mitoxantrone—sarcoma	0.00269	0.0219	CcSEcCtD
Bimatoprost—PTGER3—lymph node—sarcoma	0.00263	0.0263	CbGeAlD
Bimatoprost—Urine analysis abnormal—Mitoxantrone—sarcoma	0.00254	0.0206	CcSEcCtD
Bimatoprost—AKR1C3—testis—sarcoma	0.00236	0.0236	CbGeAlD
Bimatoprost—AKR1C3—liver—sarcoma	0.00223	0.0223	CbGeAlD
Bimatoprost—PTGFR—lymph node—sarcoma	0.00211	0.0211	CbGeAlD
Bimatoprost—Skin discolouration—Thiotepa—sarcoma	0.00191	0.0155	CcSEcCtD
Bimatoprost—Cataract—Thiotepa—sarcoma	0.00181	0.0147	CcSEcCtD
Bimatoprost—AKR1C3—lymph node—sarcoma	0.00171	0.0171	CbGeAlD
Bimatoprost—Cystitis noninfective—Thiotepa—sarcoma	0.00169	0.0137	CcSEcCtD
Bimatoprost—Cystitis—Thiotepa—sarcoma	0.00167	0.0135	CcSEcCtD
Bimatoprost—Photophobia—Thiotepa—sarcoma	0.00162	0.0132	CcSEcCtD
Bimatoprost—Bladder pain—Thiotepa—sarcoma	0.00156	0.0127	CcSEcCtD
Bimatoprost—Skin discolouration—Etoposide—sarcoma	0.00137	0.0112	CcSEcCtD
Bimatoprost—Inflammation—Etoposide—sarcoma	0.00128	0.0104	CcSEcCtD
Bimatoprost—Urine abnormality—Epirubicin—sarcoma	0.00126	0.0102	CcSEcCtD
Bimatoprost—Lacrimation—Epirubicin—sarcoma	0.00118	0.00961	CcSEcCtD
Bimatoprost—Urine analysis abnormal—Epirubicin—sarcoma	0.00118	0.00961	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Epirubicin—sarcoma	0.00117	0.0095	CcSEcCtD
Bimatoprost—Urine abnormality—Doxorubicin—sarcoma	0.00116	0.00944	CcSEcCtD
Bimatoprost—Liver function test abnormal—Dactinomycin—sarcoma	0.00115	0.00933	CcSEcCtD
Bimatoprost—Lacrimation—Doxorubicin—sarcoma	0.00109	0.00889	CcSEcCtD
Bimatoprost—Urine analysis abnormal—Doxorubicin—sarcoma	0.00109	0.00889	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Doxorubicin—sarcoma	0.00108	0.00879	CcSEcCtD
Bimatoprost—Keratitis—Epirubicin—sarcoma	0.00107	0.00871	CcSEcCtD
Bimatoprost—Burning sensation—Epirubicin—sarcoma	0.001	0.00813	CcSEcCtD
Bimatoprost—Keratitis—Doxorubicin—sarcoma	0.000992	0.00806	CcSEcCtD
Bimatoprost—Burning sensation—Doxorubicin—sarcoma	0.000926	0.00752	CcSEcCtD
Bimatoprost—Scotoma—Epirubicin—sarcoma	0.000916	0.00744	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00087	0.00706	CcSEcCtD
Bimatoprost—Stinging—Epirubicin—sarcoma	0.000858	0.00697	CcSEcCtD
Bimatoprost—Pharyngitis—Dactinomycin—sarcoma	0.000854	0.00694	CcSEcCtD
Bimatoprost—Depression—Vincristine—sarcoma	0.000854	0.00694	CcSEcCtD
Bimatoprost—Connective tissue disorder—Thiotepa—sarcoma	0.000852	0.00692	CcSEcCtD
Bimatoprost—Scotoma—Doxorubicin—sarcoma	0.000847	0.00688	CcSEcCtD
Bimatoprost—Eye disorder—Thiotepa—sarcoma	0.000811	0.00658	CcSEcCtD
Bimatoprost—Stinging—Doxorubicin—sarcoma	0.000794	0.00645	CcSEcCtD
Bimatoprost—Angiopathy—Thiotepa—sarcoma	0.000787	0.00639	CcSEcCtD
Bimatoprost—Sinusitis—Mitoxantrone—sarcoma	0.000783	0.00636	CcSEcCtD
Bimatoprost—Mediastinal disorder—Thiotepa—sarcoma	0.000782	0.00635	CcSEcCtD
Bimatoprost—Skin discolouration—Epirubicin—sarcoma	0.00077	0.00625	CcSEcCtD
Bimatoprost—Cough increased—Epirubicin—sarcoma	0.00076	0.00617	CcSEcCtD
Bimatoprost—Connective tissue disorder—Vincristine—sarcoma	0.000756	0.00614	CcSEcCtD
Bimatoprost—Erythema—Thiotepa—sarcoma	0.000755	0.00613	CcSEcCtD
Bimatoprost—Lacrimation increased—Epirubicin—sarcoma	0.000755	0.00613	CcSEcCtD
Bimatoprost—Rhinitis—Mitoxantrone—sarcoma	0.000751	0.0061	CcSEcCtD
Bimatoprost—Erythema—Dactinomycin—sarcoma	0.000749	0.00609	CcSEcCtD
Bimatoprost—Pharyngitis—Mitoxantrone—sarcoma	0.000743	0.00604	CcSEcCtD
Bimatoprost—Tension—Thiotepa—sarcoma	0.000741	0.00602	CcSEcCtD
Bimatoprost—Nervousness—Thiotepa—sarcoma	0.000733	0.00596	CcSEcCtD
Bimatoprost—Inflammation—Epirubicin—sarcoma	0.000717	0.00582	CcSEcCtD
Bimatoprost—Skin discolouration—Doxorubicin—sarcoma	0.000712	0.00579	CcSEcCtD
Bimatoprost—Vision blurred—Thiotepa—sarcoma	0.000712	0.00578	CcSEcCtD
Bimatoprost—Cough increased—Doxorubicin—sarcoma	0.000703	0.00571	CcSEcCtD
Bimatoprost—Lacrimation increased—Doxorubicin—sarcoma	0.000698	0.00567	CcSEcCtD
Bimatoprost—Angiopathy—Vincristine—sarcoma	0.000698	0.00567	CcSEcCtD
Bimatoprost—Mediastinal disorder—Vincristine—sarcoma	0.000693	0.00563	CcSEcCtD
Bimatoprost—Cystitis noninfective—Epirubicin—sarcoma	0.000679	0.00552	CcSEcCtD
Bimatoprost—Cystitis—Epirubicin—sarcoma	0.000672	0.00545	CcSEcCtD
Bimatoprost—Inflammation—Doxorubicin—sarcoma	0.000663	0.00539	CcSEcCtD
Bimatoprost—Cough—Thiotepa—sarcoma	0.000659	0.00535	CcSEcCtD
Bimatoprost—Erythema—Mitoxantrone—sarcoma	0.000652	0.0053	CcSEcCtD
Bimatoprost—Hypertension—Thiotepa—sarcoma	0.000652	0.00529	CcSEcCtD
Bimatoprost—Dry eye—Epirubicin—sarcoma	0.000642	0.00522	CcSEcCtD
Bimatoprost—Anxiety—Thiotepa—sarcoma	0.000641	0.0052	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000638	0.00519	CcSEcCtD
Bimatoprost—Bladder pain—Epirubicin—sarcoma	0.000629	0.00511	CcSEcCtD
Bimatoprost—Cystitis noninfective—Doxorubicin—sarcoma	0.000629	0.00511	CcSEcCtD
Bimatoprost—Cystitis—Doxorubicin—sarcoma	0.000621	0.00505	CcSEcCtD
Bimatoprost—Vision blurred—Mitoxantrone—sarcoma	0.000614	0.00499	CcSEcCtD
Bimatoprost—Infection—Thiotepa—sarcoma	0.000612	0.00497	CcSEcCtD
Bimatoprost—Infection—Dactinomycin—sarcoma	0.000608	0.00494	CcSEcCtD
Bimatoprost—Nervous system disorder—Thiotepa—sarcoma	0.000604	0.00491	CcSEcCtD
Bimatoprost—Vertigo—Vincristine—sarcoma	0.000602	0.00489	CcSEcCtD
Bimatoprost—Skin disorder—Thiotepa—sarcoma	0.000599	0.00486	CcSEcCtD
Bimatoprost—Dry eye—Doxorubicin—sarcoma	0.000594	0.00483	CcSEcCtD
Bimatoprost—Eye disorder—Etoposide—sarcoma	0.000582	0.00473	CcSEcCtD
Bimatoprost—Bladder pain—Doxorubicin—sarcoma	0.000582	0.00473	CcSEcCtD
Bimatoprost—Hypertension—Vincristine—sarcoma	0.000578	0.0047	CcSEcCtD
Bimatoprost—Cough—Mitoxantrone—sarcoma	0.000569	0.00462	CcSEcCtD
Bimatoprost—Angiopathy—Etoposide—sarcoma	0.000565	0.00459	CcSEcCtD
Bimatoprost—Hypertension—Mitoxantrone—sarcoma	0.000563	0.00457	CcSEcCtD
Bimatoprost—Mediastinal disorder—Etoposide—sarcoma	0.000562	0.00456	CcSEcCtD
Bimatoprost—Eye pain—Epirubicin—sarcoma	0.000559	0.00454	CcSEcCtD
Bimatoprost—Chest pain—Mitoxantrone—sarcoma	0.000555	0.00451	CcSEcCtD
Bimatoprost—Anxiety—Mitoxantrone—sarcoma	0.000553	0.00449	CcSEcCtD
Bimatoprost—Somnolence—Thiotepa—sarcoma	0.000548	0.00445	CcSEcCtD
Bimatoprost—Infection—Vincristine—sarcoma	0.000543	0.00441	CcSEcCtD
Bimatoprost—Dyspepsia—Thiotepa—sarcoma	0.000542	0.00441	CcSEcCtD
Bimatoprost—Nervous system disorder—Vincristine—sarcoma	0.000536	0.00435	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Thiotepa—sarcoma	0.000532	0.00432	CcSEcCtD
Bimatoprost—Infection—Mitoxantrone—sarcoma	0.000529	0.00429	CcSEcCtD
Bimatoprost—Pain—Thiotepa—sarcoma	0.000527	0.00428	CcSEcCtD
Bimatoprost—Pain—Dactinomycin—sarcoma	0.000523	0.00425	CcSEcCtD
Bimatoprost—Eye pain—Doxorubicin—sarcoma	0.000517	0.0042	CcSEcCtD
Bimatoprost—Skin disorder—Mitoxantrone—sarcoma	0.000517	0.0042	CcSEcCtD
Bimatoprost—Diplopia—Epirubicin—sarcoma	0.000505	0.0041	CcSEcCtD
Bimatoprost—Insomnia—Vincristine—sarcoma	0.000494	0.00401	CcSEcCtD
Bimatoprost—Vertigo—Etoposide—sarcoma	0.000487	0.00396	CcSEcCtD
Bimatoprost—Dyspnoea—Mitoxantrone—sarcoma	0.000474	0.00385	CcSEcCtD
Bimatoprost—Cough—Etoposide—sarcoma	0.000473	0.00384	CcSEcCtD
Bimatoprost—Somnolence—Mitoxantrone—sarcoma	0.000473	0.00384	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Vincristine—sarcoma	0.000472	0.00383	CcSEcCtD
Bimatoprost—Dyspepsia—Mitoxantrone—sarcoma	0.000468	0.0038	CcSEcCtD
Bimatoprost—Hypertension—Etoposide—sarcoma	0.000468	0.0038	CcSEcCtD
Bimatoprost—Pain—Vincristine—sarcoma	0.000467	0.0038	CcSEcCtD
Bimatoprost—Diplopia—Doxorubicin—sarcoma	0.000467	0.00379	CcSEcCtD
Bimatoprost—Liver function test abnormal—Epirubicin—sarcoma	0.000466	0.00379	CcSEcCtD
Bimatoprost—Dry skin—Epirubicin—sarcoma	0.000463	0.00376	CcSEcCtD
Bimatoprost—Chest pain—Etoposide—sarcoma	0.000462	0.00375	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000459	0.00372	CcSEcCtD
Bimatoprost—Pain—Mitoxantrone—sarcoma	0.000455	0.0037	CcSEcCtD
Bimatoprost—Nasopharyngitis—Epirubicin—sarcoma	0.000451	0.00367	CcSEcCtD
Bimatoprost—Asthenia—Thiotepa—sarcoma	0.000442	0.00359	CcSEcCtD
Bimatoprost—Infection—Etoposide—sarcoma	0.00044	0.00357	CcSEcCtD
Bimatoprost—Asthenia—Dactinomycin—sarcoma	0.000439	0.00356	CcSEcCtD
Bimatoprost—Asthma—Epirubicin—sarcoma	0.000436	0.00354	CcSEcCtD
Bimatoprost—Pruritus—Thiotepa—sarcoma	0.000436	0.00354	CcSEcCtD
Bimatoprost—Liver function test abnormal—Doxorubicin—sarcoma	0.000431	0.0035	CcSEcCtD
Bimatoprost—Skin disorder—Etoposide—sarcoma	0.00043	0.00349	CcSEcCtD
Bimatoprost—Dry skin—Doxorubicin—sarcoma	0.000428	0.00348	CcSEcCtD
Bimatoprost—Bronchitis—Epirubicin—sarcoma	0.00042	0.00341	CcSEcCtD
Bimatoprost—Nasopharyngitis—Doxorubicin—sarcoma	0.000418	0.00339	CcSEcCtD
Bimatoprost—Dizziness—Thiotepa—sarcoma	0.000407	0.00331	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Epirubicin—sarcoma	0.000406	0.00329	CcSEcCtD
Bimatoprost—Asthma—Doxorubicin—sarcoma	0.000404	0.00328	CcSEcCtD
Bimatoprost—Dyspnoea—Etoposide—sarcoma	0.000395	0.00321	CcSEcCtD
Bimatoprost—Somnolence—Etoposide—sarcoma	0.000394	0.0032	CcSEcCtD
Bimatoprost—Asthenia—Vincristine—sarcoma	0.000392	0.00318	CcSEcCtD
Bimatoprost—Rash—Thiotepa—sarcoma	0.000389	0.00316	CcSEcCtD
Bimatoprost—Bronchitis—Doxorubicin—sarcoma	0.000388	0.00315	CcSEcCtD
Bimatoprost—Dermatitis—Thiotepa—sarcoma	0.000388	0.00315	CcSEcCtD
Bimatoprost—Headache—Thiotepa—sarcoma	0.000386	0.00314	CcSEcCtD
Bimatoprost—Rash—Dactinomycin—sarcoma	0.000386	0.00313	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Etoposide—sarcoma	0.000382	0.0031	CcSEcCtD
Bimatoprost—Asthenia—Mitoxantrone—sarcoma	0.000382	0.0031	CcSEcCtD
Bimatoprost—Pain—Etoposide—sarcoma	0.000379	0.00307	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000375	0.00305	CcSEcCtD
Bimatoprost—Nausea—Thiotepa—sarcoma	0.000366	0.00297	CcSEcCtD
Bimatoprost—Sinusitis—Epirubicin—sarcoma	0.000365	0.00296	CcSEcCtD
Bimatoprost—Nausea—Dactinomycin—sarcoma	0.000363	0.00295	CcSEcCtD
Bimatoprost—Dizziness—Vincristine—sarcoma	0.000361	0.00293	CcSEcCtD
Bimatoprost—Rhinitis—Epirubicin—sarcoma	0.00035	0.00284	CcSEcCtD
Bimatoprost—Pharyngitis—Epirubicin—sarcoma	0.000347	0.00282	CcSEcCtD
Bimatoprost—Rash—Vincristine—sarcoma	0.000345	0.0028	CcSEcCtD
Bimatoprost—Dermatitis—Vincristine—sarcoma	0.000344	0.0028	CcSEcCtD
Bimatoprost—Oedema peripheral—Epirubicin—sarcoma	0.000344	0.00279	CcSEcCtD
Bimatoprost—Connective tissue disorder—Epirubicin—sarcoma	0.000343	0.00279	CcSEcCtD
Bimatoprost—Headache—Vincristine—sarcoma	0.000342	0.00278	CcSEcCtD
Bimatoprost—Sinusitis—Doxorubicin—sarcoma	0.000338	0.00274	CcSEcCtD
Bimatoprost—Visual impairment—Epirubicin—sarcoma	0.000337	0.00273	CcSEcCtD
Bimatoprost—Rash—Mitoxantrone—sarcoma	0.000336	0.00273	CcSEcCtD
Bimatoprost—Dermatitis—Mitoxantrone—sarcoma	0.000335	0.00272	CcSEcCtD
Bimatoprost—Headache—Mitoxantrone—sarcoma	0.000333	0.00271	CcSEcCtD
Bimatoprost—Eye disorder—Epirubicin—sarcoma	0.000326	0.00265	CcSEcCtD
Bimatoprost—Nausea—Vincristine—sarcoma	0.000325	0.00264	CcSEcCtD
Bimatoprost—Rhinitis—Doxorubicin—sarcoma	0.000324	0.00263	CcSEcCtD
Bimatoprost—Pharyngitis—Doxorubicin—sarcoma	0.000321	0.00261	CcSEcCtD
Bimatoprost—Oedema peripheral—Doxorubicin—sarcoma	0.000318	0.00259	CcSEcCtD
Bimatoprost—Asthenia—Etoposide—sarcoma	0.000318	0.00258	CcSEcCtD
Bimatoprost—Connective tissue disorder—Doxorubicin—sarcoma	0.000318	0.00258	CcSEcCtD
Bimatoprost—Angiopathy—Epirubicin—sarcoma	0.000317	0.00257	CcSEcCtD
Bimatoprost—Nausea—Mitoxantrone—sarcoma	0.000316	0.00257	CcSEcCtD
Bimatoprost—Mediastinal disorder—Epirubicin—sarcoma	0.000315	0.00256	CcSEcCtD
Bimatoprost—Pruritus—Etoposide—sarcoma	0.000313	0.00254	CcSEcCtD
Bimatoprost—Visual impairment—Doxorubicin—sarcoma	0.000311	0.00253	CcSEcCtD
Bimatoprost—Erythema—Epirubicin—sarcoma	0.000304	0.00247	CcSEcCtD
Bimatoprost—Eye disorder—Doxorubicin—sarcoma	0.000302	0.00245	CcSEcCtD
Bimatoprost—Tension—Epirubicin—sarcoma	0.000298	0.00242	CcSEcCtD
Bimatoprost—Nervousness—Epirubicin—sarcoma	0.000295	0.0024	CcSEcCtD
Bimatoprost—Angiopathy—Doxorubicin—sarcoma	0.000293	0.00238	CcSEcCtD
Bimatoprost—Dizziness—Etoposide—sarcoma	0.000293	0.00238	CcSEcCtD
Bimatoprost—Mediastinal disorder—Doxorubicin—sarcoma	0.000291	0.00237	CcSEcCtD
Bimatoprost—Vision blurred—Epirubicin—sarcoma	0.000287	0.00233	CcSEcCtD
Bimatoprost—Erythema—Doxorubicin—sarcoma	0.000281	0.00228	CcSEcCtD
Bimatoprost—Rash—Etoposide—sarcoma	0.000279	0.00227	CcSEcCtD
Bimatoprost—Dermatitis—Etoposide—sarcoma	0.000279	0.00226	CcSEcCtD
Bimatoprost—Headache—Etoposide—sarcoma	0.000277	0.00225	CcSEcCtD
Bimatoprost—Tension—Doxorubicin—sarcoma	0.000276	0.00224	CcSEcCtD
Bimatoprost—Nervousness—Doxorubicin—sarcoma	0.000273	0.00222	CcSEcCtD
Bimatoprost—Vertigo—Epirubicin—sarcoma	0.000273	0.00222	CcSEcCtD
Bimatoprost—Palpitations—Epirubicin—sarcoma	0.000269	0.00218	CcSEcCtD
Bimatoprost—Cough—Epirubicin—sarcoma	0.000265	0.00215	CcSEcCtD
Bimatoprost—Vision blurred—Doxorubicin—sarcoma	0.000265	0.00215	CcSEcCtD
Bimatoprost—Nausea—Etoposide—sarcoma	0.000263	0.00214	CcSEcCtD
Bimatoprost—Hypertension—Epirubicin—sarcoma	0.000262	0.00213	CcSEcCtD
Bimatoprost—Chest pain—Epirubicin—sarcoma	0.000259	0.0021	CcSEcCtD
Bimatoprost—Anxiety—Epirubicin—sarcoma	0.000258	0.0021	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000257	0.00209	CcSEcCtD
Bimatoprost—Dry mouth—Epirubicin—sarcoma	0.000253	0.00206	CcSEcCtD
Bimatoprost—Vertigo—Doxorubicin—sarcoma	0.000253	0.00205	CcSEcCtD
Bimatoprost—Palpitations—Doxorubicin—sarcoma	0.000249	0.00202	CcSEcCtD
Bimatoprost—Infection—Epirubicin—sarcoma	0.000246	0.002	CcSEcCtD
Bimatoprost—Cough—Doxorubicin—sarcoma	0.000245	0.00199	CcSEcCtD
Bimatoprost—Nervous system disorder—Epirubicin—sarcoma	0.000243	0.00198	CcSEcCtD
Bimatoprost—Hypertension—Doxorubicin—sarcoma	0.000243	0.00197	CcSEcCtD
Bimatoprost—Skin disorder—Epirubicin—sarcoma	0.000241	0.00196	CcSEcCtD
Bimatoprost—Chest pain—Doxorubicin—sarcoma	0.000239	0.00195	CcSEcCtD
Bimatoprost—Anxiety—Doxorubicin—sarcoma	0.000239	0.00194	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000238	0.00193	CcSEcCtD
Bimatoprost—Dry mouth—Doxorubicin—sarcoma	0.000234	0.0019	CcSEcCtD
Bimatoprost—Infection—Doxorubicin—sarcoma	0.000228	0.00185	CcSEcCtD
Bimatoprost—Nervous system disorder—Doxorubicin—sarcoma	0.000225	0.00183	CcSEcCtD
Bimatoprost—Insomnia—Epirubicin—sarcoma	0.000224	0.00182	CcSEcCtD
Bimatoprost—Skin disorder—Doxorubicin—sarcoma	0.000223	0.00181	CcSEcCtD
Bimatoprost—Dyspnoea—Epirubicin—sarcoma	0.000221	0.0018	CcSEcCtD
Bimatoprost—Somnolence—Epirubicin—sarcoma	0.000221	0.00179	CcSEcCtD
Bimatoprost—Dyspepsia—Epirubicin—sarcoma	0.000218	0.00177	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Epirubicin—sarcoma	0.000214	0.00174	CcSEcCtD
Bimatoprost—Pain—Epirubicin—sarcoma	0.000212	0.00172	CcSEcCtD
Bimatoprost—Insomnia—Doxorubicin—sarcoma	0.000208	0.00169	CcSEcCtD
Bimatoprost—Dyspnoea—Doxorubicin—sarcoma	0.000205	0.00166	CcSEcCtD
Bimatoprost—Somnolence—Doxorubicin—sarcoma	0.000204	0.00166	CcSEcCtD
Bimatoprost—Dyspepsia—Doxorubicin—sarcoma	0.000202	0.00164	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000198	0.00161	CcSEcCtD
Bimatoprost—Pain—Doxorubicin—sarcoma	0.000196	0.00159	CcSEcCtD
Bimatoprost—Asthenia—Epirubicin—sarcoma	0.000178	0.00145	CcSEcCtD
Bimatoprost—Pruritus—Epirubicin—sarcoma	0.000176	0.00143	CcSEcCtD
Bimatoprost—Asthenia—Doxorubicin—sarcoma	0.000165	0.00134	CcSEcCtD
Bimatoprost—Dizziness—Epirubicin—sarcoma	0.000164	0.00133	CcSEcCtD
Bimatoprost—Pruritus—Doxorubicin—sarcoma	0.000162	0.00132	CcSEcCtD
Bimatoprost—Rash—Epirubicin—sarcoma	0.000156	0.00127	CcSEcCtD
Bimatoprost—Dermatitis—Epirubicin—sarcoma	0.000156	0.00127	CcSEcCtD
Bimatoprost—Headache—Epirubicin—sarcoma	0.000155	0.00126	CcSEcCtD
Bimatoprost—Dizziness—Doxorubicin—sarcoma	0.000152	0.00123	CcSEcCtD
Bimatoprost—Nausea—Epirubicin—sarcoma	0.000147	0.0012	CcSEcCtD
Bimatoprost—Rash—Doxorubicin—sarcoma	0.000145	0.00118	CcSEcCtD
Bimatoprost—Dermatitis—Doxorubicin—sarcoma	0.000145	0.00117	CcSEcCtD
Bimatoprost—Headache—Doxorubicin—sarcoma	0.000144	0.00117	CcSEcCtD
Bimatoprost—Nausea—Doxorubicin—sarcoma	0.000136	0.00111	CcSEcCtD
